| EILIX | TIDDX | EILIX / TIDDX | |
| Total Expense Ratio | 1.06 | 1.08 | 98% |
| Annual Report Gross Expense Ratio | 1.23 | 1.08 | 114% |
| Fund Existence | 10 years | 10 years | - |
| Gain YTD | 3.681 | 5.129 | 72% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 500000 | 200% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 3.64M | 6.44B | 0% |
| Annual Yield % from dividends | 8.16 | 1.61 | 507% |
| Returns for 1 year | 18.68 | 24.29 | 77% |
| Returns for 3 years | 23.00 | 34.11 | 67% |
| Returns for 5 years | 5.79 | -13.09 | -44% |
| Returns for 10 years | 74.74 | 73.21 | 102% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FBTDX | 149.45 | 1.79 | +1.21% |
| Franklin Biotechnology Discovery C | |||
| JDCRX | 42.22 | 0.12 | +0.29% |
| Janus Henderson Forty R | |||
| GIRMX | 32.96 | 0.04 | +0.12% |
| Goldman Sachs Emerging Markets Eq Inv | |||
| GBFAX | 18.42 | 0.02 | +0.11% |
| VanEck Emerging Markets A | |||
| GGSYX | 17.03 | -0.03 | -0.18% |
| Grandeur Peak Global Stalwarts Instl | |||